Additional file 1: of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Published in 2016 by
Helga Munch-Petersen,
Fazila Asmar,
Konstantinos Dimopoulos,
Aušrinė Areškevičiūtė,
Peter Brown,
Mia Girkov,
Anja Pedersen,
Lene Sjö,
Steffen Heegaard,
Helle Broholm,
Lasse Kristensen,
Elisabeth Ralfkiaer,
Kirsten Grønbæk
Abstract
Methods 1. Immunohistochemistry. Methods 2. Detection and structural classification of TP53 mutations. Methods 3. DAPK methylation analysis using allellic MSP-pyrosequencing. (PDF 379 kb)